Insulin detemir is available in a 10-mL vial for a retail price of $77.99. Insulin detemir is also available in a 3-mL (100 units/mL) FlexPen. A package of five syringes is $146.99 retail. [26] ...

Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine) and biosimilars and Novo Nordisk's newer product Tresiba ...

Insulin detemir is a long-acting analogue produced by covalent acylation of the amino group of lysine in B, the 29 position, which confers a neutral pH to the insulin molecule.

We struggled at first. But after a few difficult months, we found a system that worked — involving lifestyle changes and the use of a specific long-acting insulin called Levemir (detemir).

Historically, no insulin removed from the market has successfully come back as a biosimilar, and the regulatory path remains unclear. That must change — especially for a drug so critical to pregnancy ...

Insulin is an effective hormone for people with diabetes. But interestingly, there are six types of insulin available in the market. Here’s a detailed look at them and how they work.

In addition, no data are available on the effects of insulin control on preventing dementia in CKD patients with diabetes and hypertension.” Data derived from Chen YY, et al. BMC Nephrol. 2025 ...

Indian drugmakers Biocon, Eris Lifesciences, and Wockhardt are ramping up insulin production to capture a growing global opportunity, as market leader Novo Nordisk scales back its presence in ...

A new research paper was published in Aging (Aging-US) Volume 17, Issue 5, on May 1, 2025, titled "Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets." ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs. First ...